10.21147/j.issn.1000-9604.2017.03.12
Is there an optimal time to initiate adjuvant chemotherapy to predict benefit of survival in non-small cell lung cancer?
lung cancer、curative resection、survival analysis、prognostic factor、tumor recurrence、regression model、Medical Sciences、risk factors
29
R73;R65
2017-12-11(万方平台首次上网日期,不代表论文的发表时间)
共9页
263-271